Navigation Links
Amsterdam Molecular Therapeutics Successfully Lowers Cholesterol In Vivo With Enhanced Novel MicroRNA AAV Gene Therapy
Date:10/25/2010

, France, and at the European Society for Gene and Cell Therapy Annual Conference (22-25 October) in Milan, Italy.

In the new study, mice received intra-venous injections with equal doses of 1011 gc per animal AAV-shApoB or AAV-miApoB and were examined for 18 weeks. Expression of the shApoB and miApoB resulted in 90% ApoB protein knock-down, associated with 80% cholesterol decrease in murine plasma for the first 6 weeks. However, after 8 weeks the effect of the shApoB started to wear off, while miApoB remained effective in ApoB and cholesterol reduction for up to 18 weeks. Ongoing research aims to determine the mechanism for the differences seen between long-term AAV-shApoB and AAV-miApoB efficacy in murine livers. We believe that the long-term stability of the miApoB is due to its lower toxicity and off-target properties compared to shApoB because expression of miApoB is specifically limited to hepatocytes.

ApoB100 is the structural protein of Low Density Lipoprotein (LDL) particles that carry cholesterol. Silencing the activity of ApoB100 with miRNA or shRNA lowers plasma LDL-cholesterol by 60-80% and has the potential to be used to treat hypercholesterolemia and associated cardiovascular disease.

About Amsterdam Molecular Therapeutics

AMT is a leader in the development of human gene based therapies. Using adeno-associated viral (AAV) derived vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. This proprietary platform can be applied to a large number of rare (orphan) diseases that are caused by one faulty gene. Currently, AMT has a product pipeline with several AAV-based gene therapy products in LPLD, Hemophilia B, Duchenne Muscular Dystrophy, Acute Intermittent Porphyria, and Parkinson's Disease at different stages of research or development. AMT was founded in 1998 and is based in Amsterdam.

'/>"/>
SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Amsterdam Molecular Therapeutics Reports Half-Year Results 2010
2. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
3. The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project
4. Amsterdam Molecular Therapeutics Reports Half Year Results 2009
5. Amsterdam Molecular Therapeutics Reports Full Year Results 2008
6. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
7. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
8. Molecular Detections Detect-Ready™ MRSA Assay Demonstrates Strong Performance In Independent Comparative Study From Leading UK Hospital
9. QIAGEN and Abbott Enter Into Agreement on Molecular Tests for HIV, HCV and HPV
10. New Data Suggest Veracytes Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples
11. Launch of Two New Platforms for Microplate Analysis Expands Reader Portfolio and Ensures Molecular Devices Readers Meet all Combinations of Customer Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... 2014 The International Wheat Genome Sequencing Consortium ... draft sequence of the bread wheat genome. The chromosome-based ... evolution of the large, complex genome of the world,s ... blueprint is an invaluable resource to plant science researchers ... their disposal a set of tools enabling them to ...
(Date:7/17/2014)... July 17, 2014  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the development and commercialization of products for the treatment ... release results for the second quarter of 2014 on ... The Company will host a conference call ... during which Vanda management will discuss the second quarter ...
(Date:7/17/2014)... The Scripps Research Institute (TSRI) and Hong Kong ... collaborators have found that ancient enzymes, known for ... proteins, evolved myriad other functions in humans. The ... evolution as well as a potentially valuable new ... "These new protein variants represent a previously unrecognized ...
(Date:7/17/2014)... 17, 2014  Exelixis, Inc. (Nasdaq: EXEL ... two cancer treatments cabozantinib (Cabo, Cometriq) and cobimetinib (Cobi). ... company has a partnership with Roche to commercialize, market ... in the treatment of melanoma by late 2015, after ... marketed and distributed in the U.S. by EXEL, and ...
Breaking Biology Technology:Genetic Blueprint of Bread Wheat Genome Unveiled 2Genetic Blueprint of Bread Wheat Genome Unveiled 3Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2Scientists find protein-building enzymes have metamorphosed & evolved new functions 2Scientists find protein-building enzymes have metamorphosed & evolved new functions 3Exelixis, Inc., Analyst Report; The Upside Potential is Worth the Risk by BrokerBank Securities, Inc. 2
... to Apply for Incentive Program, RALEIGH, N.C., ... around the Research Triangle Area (RTA) who provide ... the RTA Health Care,Collaborative, a group of forward-thinking ... is implementing an initiative,known as the Bridges to ...
... SAN FRANCISCO, Calif., Aug. 16 Anesiva,Inc. (Nasdaq: ... in the,Zingo(TM) development program before the markets open ... held at 8:30 a.m. Eastern Time,tomorrow to discuss ... the live audio webcast by dialing,800-340-6289 (international dial: ...
... Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today ... the U.S. Food and Drug Administration (FDA) for,VALSTAR(R). ... is the only product approved by the FDA ... (CIS) of the,urinary bladder. VALSTAR was removed ...
Cached Biology Technology:Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs 2Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs 3Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs 4Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program 2Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 2Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 3Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 4
(Date:7/21/2014)... of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in the ... the virus. The work, published this week in ... Society for Microbiology, indicates that further studies are needed ... the air. , MERS, a serious viral respiratory illness ... people as of June 11, according to the World ...
(Date:7/21/2014)... every movement, researchers have shown for the first time ... farms and pipelines. Those man-made structures probably serve as ... study published in the Cell Press journal Current ... shocked when I first saw the stunning grid pattern ... wind farm in the United Kingdom, says Deborah Russell ...
(Date:7/21/2014)... 2014 Dysfunction in dopamine signaling profoundly changes ... the brain,s prefrontal cortex and may be an ... as schizophrenia, according to UC Irvine scientists. , ... cells that receive this neurotransmitter showed for the ... variety of behavioral and physiological functions regulated in ...
Breaking Biology News(10 mins):Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2Seals forage at offshore wind farms 2UCI researchers find epigenetic tie to neuropsychiatric disorders 2
... Horizon oil spill temporarily worsened existing manmade problems in Louisiana,s ... for optimism, according to a new study. A study ... Academy of Sciences found the 2010 spill killed off ... and this plant die off resulted in a more-than-doubled rate ...
... Older women with insufficient levels of Vitamin D gained more weight ... new study funded by the National Institutes of Health and published ... study of more than 4,600 women ages 65 and older found ... D in their blood gained about two pounds more than those ...
... The international project LEGATO (Land-use intensity ... and Opportunities in irrigated rice based production systems) ... Ecosystem Services and Ecological Engineering" which will be ... 7 July. LEGATO unites 21 research institutions ...
Cached Biology News:BP Deepwater Horizon oil spill exacerbated existing environmental problems in Louisiana marshes 2BP Deepwater Horizon oil spill exacerbated existing environmental problems in Louisiana marshes 3Low vitamin D levels linked to weight gain in some older women 2
... The Jouan MSC series of Class ... working conditions and certification to the ... regulation ensures that the cabinets cannot ... conditions. Natural lighting, low noise and ...
... are designed to create the ideal environment for ... to 99.9C) , Variable speed control (10 ... whether it be for washing or hybridizing ... temperature inside the chamber, ,is situated above a ...
... engineered for efficient drying down of synthetic ... cover and a post-trap with ammonia neutralizing ... of samples in ammonium hydroxide., , ... , Comes standard with ...
... (for aqueous, other low volatility and noxious ... to specific applications of molecular biology and ... heat-labile samples. The RC systems can be ... and a wide selection of rotors (eliminating ...
Biology Products: